Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen

This study has been terminated.
Merck N.V.-S.A., Belgium
Information provided by (Responsible Party):
Merck KGaA Identifier:
First received: March 3, 2010
Last updated: July 1, 2014
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)